Vasiliki Pelekanou
Vasiliki Pelekanou
Digital Pathology Leader, Oncology Precision Medicine, Bayer Pharmaceuticals
Verified email at
Cited by
Cited by
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...
JAMA Oncology, 2015
Immunological differences between primary and metastatic breast cancer
B Szekely, V Bossuyt, X Li, VB Wali, GA Patwardhan, C Frederick, A Silber, ...
Annals of Oncology 29 (11), 2232-2239, 2018
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1
V Pelekanou, M Kampa, F Kiagiadaki, A Deli, P Theodoropoulos, ...
Journal of Leucocyte Biology 99 (2), 333-347, 2016
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
JA Rehman, G Han, DE Carvajal-Hausdorf, BE Wasserman, V Pelekanou, ...
Modern Pathology 30 (3), 340-349, 2017
Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological …
VI Alexaki, G Notas, V Pelekanou, M Kampa, M Valkanou, ...
The Journal of immunology 183 (9), 5948-5956, 2009
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
V Pelekanou, DE Carvajal-Hausdorf, M Altan, B Wasserman, ...
Breast Cancer Research 19, 1-11, 2017
Ki67 Reproducibility using Digital Image Analysis: An Inter-platform and Inter-Operator Study
B Acs, V Pelekanou, Y Bai, S Martinez-Morilla, M Toki, S Leung, ...
Laboratory Investigation, 2018
B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes
M Altan, V Pelekanou, KA Schalper, M Toki, P Gaule, K Syrigos, ...
Clinical Cancer Research 23 (17), 5202-5209, 2017
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
ES Reisenbichler, G Han, A Bellizzi, V Bossuyt, J Brock, K Cole, O Fadare, ...
Modern pathology 33 (9), 1746-1752, 2020
Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas
V Pelekanou, M Kampa, M Kafousi, K Darivianaki, E Sanidas, DD Tsiftsis, ...
BMC cancer 8, 1-9, 2008
Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial
V Pelekanou, WE Barlow, Z Nahleh, B Wasserman, YC Lo, ...
Molecular Cancer Therapeutics, 2018
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
V Pelekanou, F Villarroel-Espindola, ...
Breast Cancer Research 20 (154), 2018
Membrane-initiated steroid action in breast and prostate cancer
M Kampa, V Pelekanou, E Castanas
Steroids 73 (9-10), 953-960, 2008
Immune profiling of pre-and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
X Li, S Warren, V Pelekanou, V Wali, A Cesano, M Liu, P Danaher, ...
Journal for immunotherapy of cancer 7, 1-9, 2019
TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus
S Sabour Alaoui, V Dessirier, E De Araujo, VI Alexaki, V Pelekanou, ...
PLoS One 7 (3), e33609, 2012
Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis
V Pelekanou, G Leclercq
International Journal of Developmental Biology 55 (7-8-9), 869-878, 2011
Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells
G Notas, AP Nifli, M Kampa, V Pelekanou, VI Alexaki, P Theodoropoulos, ...
The Journal of nutritional biochemistry 23 (6), 656-666, 2012
ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines
V Pelekanou, G Notas, M Kampa, E Tsentelierou, J Radojicic, G Leclercq, ...
Steroids 77 (10), 928-934, 2012
TPL2 kinase is a suppressor of lung carcinogenesis
K Gkirtzimanaki, KK Gkouskou, U Oleksiewicz, G Nikolaidis, D Vyrla, ...
Proceedings of the National Academy of Sciences 110 (16), E1470-E1479, 2013
APRIL binding to BCMA activates a JNK2–FOXO3–GADD45 pathway and induces a G2/M cell growth arrest in liver cells
G Notas, VI Alexaki, M Kampa, V Pelekanou, I Charalampopoulos, ...
The Journal of Immunology 189 (10), 4748-4758, 2012
The system can't perform the operation now. Try again later.
Articles 1–20